Status:
RECRUITING
Pediatric Liver Transplantation-Liver Fibrosis Evaluation by Using Fibrosis Panel
Lead Sponsor:
RenJi Hospital
Conditions:
Liver Fibrosis
Pediatric Disorder
Eligibility:
All Genders
2-18 years
Phase:
NA
Brief Summary
Liver transplantation in children is highly successful with \>80% having 20 years survival. Most pediatric liver diseases are potentially curable with liver transplantation and it is important to esta...
Detailed Description
The cross-section study will be performed in pediatric patients who underwent liver transplantation from year 2016-2021. Patients will be enrolled after collecting their informed consent from their pa...
Eligibility Criteria
Inclusion
- Male or female participant must be between 8 weeks and 18 years of age.
- Participant is a recipient of a first liver allograft from cadaveric or living donors.
- Participant is a single-organ recipient (liver only).
- Participants' parent/guardian is capable of understanding the purposes and risks of the study and must sign an informed consent for the study.
Exclusion
- Participants older than 18 years of age
- Pregnant or breastfeeding
- Active systemic infections
- Receiving any form of solid organ retransplantation
- Multiorgan transplantation
- Multi organ failure
- Congenital sufferers from heart, lung, kidney, nervous system or blood disease
- Refused to participate the study
Key Trial Info
Start Date :
April 30 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 30 2025
Estimated Enrollment :
1200 Patients enrolled
Trial Details
Trial ID
NCT05308628
Start Date
April 30 2022
End Date
November 30 2025
Last Update
August 7 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Deparment of Liver Surgery, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University
Shanghai, China, 200127
2
Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University
Shanghai, China, 200127